Clinical Trial Update: A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports a completed study evaluating bone quality in osteoporosis patients treated with oral ibandronate versus placebo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Ibandronate (oral) (ibandronate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED